Ontology highlight
ABSTRACT: Background
Multiple clinical studies have indicated that the gut microbiota influences the effects of immune checkpoint blockade (ICB) therapy comprising PD-1/PD-L1 inhibitors, but the causal relationship is unclear. Because of numerous confounders, many microbes related to PD-1/PD-L1 have not been identified. This study aimed to determine the causal relationship between the microbiota and PD-1/PD-L1 and identify possible biomarkers for ICB therapy.Method
We used bidirectional two-sample Mendelian randomization with two different thresholds to explore the potential causal relationship between the microbiota and PD-1/PD-L1 and species-level microbiota GWAS to verify the result.Result
In the primary forward analysis, genus_Holdemanella showed a negative correlation wi
SUBMITTER: Huang YF
PROVIDER: S-EPMC10034163 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature